Cargando…

1471. Medical Claims Analysis as a Tool to Evaluate Empiric and Targeted Antibiotic Therapy in UTIs

BACKGROUND: Empiric therapy is a mainstay of the inpatient management of urinary tract infections (UTIs), and the choice of empiric antibiotic is shaped by local epidemiology and patient risk factors and comorbidities. Pathogen identification (ID) and antibiotic susceptibility testing (AST) provide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hui, Wing, Antunes, Nuno T, Veeramani, Shriram, Holman, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810626/ http://dx.doi.org/10.1093/ofid/ofz360.1335

Ejemplares similares

P16 UTI Friday: a review of antibiotic prophylaxis in the management of recurrent UTI in primary care
por: Tucker, Avril
Publicado: (2023)

Empiric versus culture-based antibiotic therapy for UTIs in menopausal women
por: Kusin, Samuel B., et al.
Publicado: (2023)

1471. Evaluation of Antibiotic De-escalation in Post Cardiac Arrest Patients with Culture-Negative versus Culture-Positive Aspiration Pneumonia
por: Herzig, Natasha R, et al.
Publicado: (2020)

Understanding patient and clinician perspectives of antibiotic use for the treatment of UTIs
por: Hannum, Susan, et al.
Publicado: (2020)

1471. Case Report: Andes Virus Hantavirus Pulmonary Syndrome in a Traveler Returning to the United States
por: Bergamo, David, et al.
Publicado: (2018)

42. INSPIRE-ASP UTI Trial: A 59 Hospital Cluster Randomized Evaluation of INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection versus Routine Antibiotic Selection Practices for Patients with Urinary Tract Infection (UTI)
por: Gohil, Shruti K, et al.
Publicado: (2021)

1433. Impact of 2019 US Food and Drug Administration (FDA) Guidance on Developing Drugs for Urinary Tract Infection (UTI) on the Perceived Efficacy of Antibiotics for the Treatment of Uncomplicated UTI (uUTI)
por: Henriksen, Anne Santerre, et al.
Publicado: (2021)

Acute Uncomplicated UTI and E. coli Resistance: Implications for First-Line Empirical Antibiotic Therapy
por: Perfetto, Eleanor M,, et al.
Publicado: (2004)

Complete Genome Sequence of Blautia producta JCM 1471(T)
por: Tourlousse, Dieter M., et al.
Publicado: (2020)

1471 A Pilot Study to Introduce Voluntary Medical Male Circumcision for HIV Prevention in Areas of High Prevalence of the Dominican Republic
por: Brito, Maximo, et al.
Publicado: (2014)

2238. Estimating the impact of antibiotic exposure on antibiotic resistance in uncomplicated UTI using machine learning causal inference
por: Kanjilal, Sanjat, et al.
Publicado: (2022)

1521. Heterogeneity of Recent Phase 3 cUTI Clinical Trials with New Antibiotics
por: Bass, Almasa, et al.
Publicado: (2018)

1696. The Black Box of Using Health Claims-Based Analyses to Estimate UTI Prevalence in Community-Dwelling Women
por: Stapleton, Ann E, et al.
Publicado: (2020)

1471. Identifying Modifiable Risk Factors for Colorectal Surgical Site Infections at a Large Safety Net Hospital: A Case-Control Study
por: Mundra, Vatsala, et al.
Publicado: (2023)

2417. Risk Factors, Response to Empiric Therapy, and Healthcare Utilization Among Children With UTI Due to Extended Spectrum β-Lactamase-Producing Enterobacteriaceae
por: Dasgupta-Tsinikas, Shom, et al.
Publicado: (2018)

1232 Antibiotic Stewardship for Urinary Tract Infections (UTI): Impact on Therapy and Clinical Outcomes
por: Gill, Veenu, et al.
Publicado: (2014)

Antibiotic Bladder Irrigation in Preventing and Reducing Chronic Urinary Catheter-Related Urinary Tract Infections (UTI)
por: Harmon, Christian, et al.
Publicado: (2017)

1449. Antibiotic Choice, Duration, and Outcome in Community-Acquired Urinary Tract Infections (UTI) in Male Patients
por: Chen, Joshua C, et al.
Publicado: (2019)

2209. Reducing Inappropriate Antibiotic Prescribing for the Treatment of Urinary Tract Infections (UTI) in Urgent Care Clinics
por: Vu, Christine A, et al.
Publicado: (2023)

140. Impact of Pharmacist-led Audit & Feedback on Outpatient Antibiotic Prescribing for UTIs and SSTIs
por: Choi, Patricia, et al.
Publicado: (2020)

Sex difference in inappropriate therapy and survival among 1471 implantable cardioverter‐defibrillator recipients
por: Burger, Achim Leo, et al.
Publicado: (2019)

1082. Hold the Phone: Antibiotic Prescribing Practices Associated with Nonvisit Encounters for Urinary Tract Infections (UTIs) in Urology Clinics
por: Akbar, Nina, et al.
Publicado: (2019)

1330. Development of a Pediatric Emergency Department (ED) Uropathogen Antibiogram and Empiric Urinary Tract Infection (UTI) Treatment Algorithm
por: Dass, Akshith M, et al.
Publicado: (2020)

1425. Revisiting β-Lactams for Treatment of Uncomplicated Urinary Tract Infections: Evaluation of Twice-daily Cephalexin for Empiric Treatment of UTIs
por: Benning, Molly, et al.
Publicado: (2021)

Is fosfomycin as effective as claimed on MDR Gram-negative bacteria causing UTI? [Letter]
por: Singh, Geeta, et al.
Publicado: (2019)

1431. Comparison of Treatment Outcomes with Definitive Antibiotic Therapy and Empiric Antibiotic Therapy in Osteomyelitis
por: Holzum, Dorothy, et al.
Publicado: (2019)

Etiology of UTI – pathogens involved and their sensitivity to antibiotics
por: Carp, Sorina, et al.
Publicado: (2014)

Practical Story: Real People, Real Urine, Unreal UTI
por: Offiong, Charlene, et al.
Publicado: (2019)

104. Accuracy of ChatGPT for UTI Diagnosis and Management Questions
por: Gupta, Kalpana, et al.
Publicado: (2023)

1133. Opportunities for Antibiotic Discontinuation and De-escalation after Discharge from the Emergency Department in Pediatric Patients with UTI
por: Hawkins, Stephanie, et al.
Publicado: (2021)

189. Optimizing Empiric Antibiotic Therapy: a Probabilistic Approach
por: Couto, Bráulio R G M, et al.
Publicado: (2022)

“Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]
por: Gopichand, Pallam, et al.
Publicado: (2019)

1635. Analysis of Antibiotic-Related Malpractice Claims, 2007 to 2016
por: Kabbani, Sarah, et al.
Publicado: (2019)

Co-Amoxiclav as empiric treatment of UTI in children: importance of surveillance in ensuring optimal empiric treatment choice
por: Trayer, James, et al.
Publicado: (2021)

191. Appropriateness of Empiric Antibiotics for Enterobacteriaceae Bacteremia
por: Smith, Brandon J, et al.
Publicado: (2019)

1237. New York State Outpatient Regional Antibiogram for Urinary Pathogens: Have We Reached a Post Antibiotic Era for the Treatment of UTIs?
por: Rank, Elliot, et al.
Publicado: (2018)

1522. Initial Clinical Response of Children with Extended-Spectrum Cephalosporin-Resistant Urinary Tract Infections (ESC-R UTI’s) Started on Discordant Antibiotics
por: Wang, Marie, et al.
Publicado: (2018)

2222. 3-Day Ceftriaxone vs. Longer Durations of Therapy For Inpatient Treatment of Uncomplicated UTI 
por: Elajouz, Balsam, et al.
Publicado: (2022)

1048. A Randomized Controlled Trial of an Electronic Tool for Empiric Antibiotic Prescription: Results from the ANti-infective Stewardship using the WISCA tool in the Electronic Medical Record (AnSWER) Study
por: Ridgway, Jessica, et al.
Publicado: (2019)

1420. Descriptive Epidemiology of UTI Hospitalizations in the US, 2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7bgjva4b414dkshr72al3c2ml3